Biospecimens and biorepositories: from afterthought to science
- PMID: 22313938
- PMCID: PMC3277207
- DOI: 10.1158/1055-9965.EPI-11-1179
Biospecimens and biorepositories: from afterthought to science
Abstract
Biospecimens are recognized as critical components of biomedical research, from basic studies to clinical trials and epidemiologic investigations. Biorepositories have existed in various forms for more than 150 years, from early small collections in pathology laboratories to modern automated facilities managing millions of samples. As collaborative science has developed, it has been recognized that biospecimens must be of consistent quality. Recent years have seen a proliferation of best practices and the recognition of the field of "biospecimen science." The future of this field will depend on the development of more evidence-based practices in both the research and clinical settings. As the field matures, educating a new generation of biospecimen/biobanking scientists will be an important need.
©2011 AACR.
References
-
- American Association for Cancer Research. Fourth Conference on The Science of Cancer Health Disparities; Available from: http://www.aacr.org/home/scientists/meetings--workshops/cancer-health-di....
-
- Eiseman E, Haga S. A Handbook of Human Tissue Sources: a National Resource of Human Tissue Samples. Santa Monica, CA: RAND Corporation; 2000.
-
- Wolff AC, Hammond ME, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor testing in breast cancer. Arch Pathol Lab Med. 2007;131:18–43. - PubMed
-
- Silberman S. Wired. Jun, 2010. The flesh files; p. 157.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials